BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 147 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $23,000 | 0.0% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $23,000 | -14.8% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $27,000 | 0.0% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $27,000 | -6.9% | 7,500 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $29,000 | -9.4% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $32,000 | +14.3% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $28,000 | -39.1% | 7,500 | -28.6% | 0.00% | -33.3% |
| Q2 2020 | $46,000 | +15.0% | 10,500 | 0.0% | 0.00% | -25.0% |
| Q1 2020 | $40,000 | -39.4% | 10,500 | 0.0% | 0.00% | -20.0% |
| Q4 2019 | $66,000 | +50.0% | 10,500 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $44,000 | -10.2% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $49,000 | -48.4% | 10,500 | -41.7% | 0.00% | -50.0% |
| Q1 2019 | $95,000 | +265.4% | 18,000 | +1340.0% | 0.01% | +166.7% |
| Q4 2018 | $26,000 | -49.0% | 1,250 | -93.1% | 0.00% | -25.0% |
| Q3 2018 | $51,000 | +37.8% | 18,000 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $37,000 | 0.0% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $37,000 | -30.2% | 18,000 | 0.0% | 0.00% | -40.0% |
| Q4 2017 | $53,000 | -29.3% | 18,000 | -29.4% | 0.01% | 0.0% |
| Q3 2017 | $75,000 | +53.1% | 25,500 | +41.7% | 0.01% | +66.7% |
| Q2 2017 | $49,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Capital Management | 1,000 | $3,000 | 0.00% |
| Close Asset Management Ltd | 7,500 | $23,000 | 0.00% |
| IFP Advisors, Inc | 250 | $1,000 | 0.00% |